Patents by Inventor Sarah Pogue

Sarah Pogue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies
    Patent number: 9932411
    Abstract: The invention provides antibodies which bind to the extracellular domain of the Tyrosine-protein kinase transmembrane receptor Matriptase. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including gastric cancer, colorectal cancer, prostate cancer, breast cancer, ovarian cancer lung cancer, preferably SCLC, esophageal cancer, head and neck cancer, pancreatic cancer, lymphoma preferably non-Hodgkin's lymphoma and skin cancer.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: April 3, 2018
    Assignee: Oxford BioTherapeutics Ltd
    Inventors: Jonathan Alexander Terrett, Chetana Rao-Naik, Haichun Huang, Sarah Pogue, Erika Meaddough, Michelle Kuhne, Chin Pan
  • ANTIBODIES ANTI MATRIPTASE FOR THE TREATMENT OF CANCER
    Publication number: 20160289338
    Abstract: The invention provides antibodies which bind to the extracellular domain of the Tyrosine-protein kinase transmembrane receptor Matriptase. Nucleic acid molecules encoding the antibodies, expression vectors, host cells and methods for expressing the antibodies are also provided. The antibodies may be used for the treatment of cancer, including gastric cancer, colorectal cancer, prostate cancer, breast cancer, ovarian cancer lung cancer, preferably SCLC, esophageal cancer, head and neck cancer, pancreatic cancer, lymphoma preferably non-Hodgkin's lymphoma and skin cancer.
    Type: Application
    Filed: November 25, 2014
    Publication date: October 6, 2016
    Inventors: Jonathan Alexander TERRETT, Chetana RAO-NAIK, Haichun HUANG, Sarah POGUE, Erika MEADDOUGH, Michelle KUHNE, Chin PAN
  • Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
    Publication number: 20050208041
    Abstract: Humanized monoclonal antibodies which bind to IFNAR-1, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the humanized antibodies and therapeutic and diagnostic methods for using the humanized antibodies.
    Type: Application
    Filed: April 23, 2004
    Publication date: September 22, 2005
    Applicant: Medarex, Inc.
    Inventors: Josephine Cardarelli, Tseng-hui Chen, David King, Christopher Bebbington, Sarah Pogue, Francis Carr, Stephen Williams